![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/473 | (2006.01) |
A61K 31/485 | (2013.01) | ||
A61K 31/13 | (2006.01) | ||
C07D 221/18 | (2013.01) | ||
C07D 401/06 | (2013.01) | ||
A61K 31/485 | (2006.01) | ||
C07D 409/06 | (2013.01) | ||
C07D 221/02 | (2006.01) | ||
C07D 489/00 | (2006.01) | ||
C07D 489/02 | (2013.01) | ||
A61K 9/00 | (2006.01) | ||
C07D 211/34 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 9/50 | (2006.01) | ||
A61K 31/137 | (2013.01) | ||
A61K 31/165 | (2013.01) | ||
A61P 25/00 | (2006.01) | ||
A61K 31/445 | (2013.01) | ||
A61K 9/48 | (2006.01) | ||
A61K 31/4458 | (2013.01) | ||
A61K 9/16 | (2006.01) | ||
A61K 31/4468 | (2013.01) | ||
A61K 9/28 | (2006.01) | ||
A61K 31/137 | (2006.01) | ||
A61K 31/4535 | (2013.01) | ||
A61K 31/165 | (2006.01) | ||
A61K 31/454 | (2013.01) | ||
A61K 31/445 | (2006.01) | ||
A61K 31/473 | (2013.01) | ||
A61K 31/4458 | (2006.01) | ||
A61K 36/74 | (2013.01) | ||
A61K 31/4468 | (2006.01) | ||
A61K 9/2886 | (2013.01) | ||
A61K 31/4535 | (2006.01) | ||
A61K 9/5078 | (2013.01) | ||
A61K 31/454 | (2006.01) | ||
A61K 9/5084 | (2013.01) | ||
A61K 36/74 | (2006.01) | ||
A61K 9/1676 | (2013.01) | ||
A61P 25/00 | (2018.01) |
(11) | Number of the document | 3294278 |
(13) | Kind of document | T |
(96) | European patent application number | 16792259.0 |
Date of filing the European patent application | 2016-05-11 | |
(97) | Date of publication of the European application | 2018-03-21 |
(45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2016/000688 |
Date | 2016-05-11 |
(87) | Number | WO 2016/181218 |
Date | 2016-11-17 |
(30) | Number | Date | Country code |
201562160627 P | 2015-05-13 | US |
(72) |
SELA, Yoram , IL
LAMENSDORF, Itschak , IL
|
(73) |
4P-Pharma ,
Campus de l'Institut Pasteur de Lille
1, rue du Professeur Calmette, 59000 Lille,
FR
|
(54) | APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY |
APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY |